| Chitosan and their derivatives: Antibiofilm drugs against pathogenic bacteria F Khan, DTN Pham, SF Oloketuyi, P Manivasagan, J Oh, YM Kim Colloids and Surfaces B: Biointerfaces 185, 110627, 2020 | 212 | 2020 |
| Fucoidan-Stabilized Gold Nanoparticle-Mediated Biofilm Inhibition, Attenuation of Virulence and Motility Properties in Pseudomonas aeruginosa PAO1 F Khan, P Manivasagan, JW Lee, DTN Pham, J Oh, YM Kim Marine drugs 17 (4), 208, 2019 | 102 | 2019 |
| Role of material combination and new results of mechanical behavior for FG sandwich plates in thermal environment TV Do, TQ Bui, TT Yu, DT Pham, CT Nguyen Journal of computational science 21, 164-181, 2017 | 86 | 2017 |
| Regulation and controlling the motility properties of Pseudomonas aeruginosa F Khan, DTN Pham, SF Oloketuyi, YM Kim Applied microbiology and biotechnology 104, 33-49, 2020 | 81 | 2020 |
| Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease E Hayase, T Hayase, MA Jamal, T Miyama, CC Chang, MR Ortega, ... Cell 185 (20), 3705-3719. e14, 2022 | 68 | 2022 |
| Antibiofilm and antivirulence properties of chitosan-polypyrrole nanocomposites to Pseudomonas aeruginosa F Khan, P Manivasagan, DTN Pham, J Oh, SK Kim, YM Kim Microbial pathogenesis 128, 363-373, 2019 | 68 | 2019 |
| Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis TM Halsey, AS Thomas, T Hayase, W Ma, H Abu-Sbeih, B Sun, ER Parra, ... Science translational medicine 15 (700), eabq4006, 2023 | 65 | 2023 |
| Synthesis and characterization of chitosan oligosaccharide-capped gold nanoparticles as an effective antibiofilm drug against the Pseudomonas aeruginosa PAO1 F Khan, JW Lee, P Manivasagan, DTN Pham, J Oh, YM Kim Microbial Pathogenesis 135, 103623, 2019 | 65 | 2019 |
| Treatment strategies targeting persister cell formation in bacterial pathogens F Khan, DTN Pham, N Tabassum, SF Oloketuyi, YM Kim Critical Reviews in Microbiology 46 (6), 665-688, 2020 | 53 | 2020 |
| The impact of CEO duality on firm performance: Examining the life-cycle theory in Vietnam D Pham, Q Pham Accounting 6 (5), 737-747, 2020 | 50 | 2020 |
| Genitourinary Defects Associated with Genomic Deletions in 2p15 Encompassing OTX1 CJ Jorgez, JA Rosenfeld, NR Wilken, HV Vangapandu, A Sahin, D Pham, ... PLoS One 9 (9), e107028, 2014 | 49 | 2014 |
| Mixed biofilms of pathogenic Candida-bacteria: regulation mechanisms and treatment strategies F Khan, NI Bamunuarachchi, DTN Pham, N Tabassum, MSA Khan, ... Critical reviews in microbiology 47 (6), 699-727, 2021 | 47 | 2021 |
| Streptomycin mediated biofilm inhibition and suppression of virulence properties in Pseudomonas aeruginosa PAO1 F Khan, JW Lee, DTN Pham, JH Lee, HW Kim, YK Kim, YM Kim Applied Microbiology and Biotechnology 104, 799-816, 2020 | 47 | 2020 |
| Biofilm inhibition, modulation of virulence and motility properties by FeOOH nanoparticle in Pseudomonas aeruginosa DTN Pham, F Khan, TTV Phan, S Park, P Manivasagan, J Oh, YM Kim Brazilian Journal of Microbiology 50, 791-805, 2019 | 41 | 2019 |
| Alternative strategies for the application of aminoglycoside antibiotics against the biofilm-forming human pathogenic bacteria F Khan, DTN Pham, YM Kim Applied microbiology and biotechnology 104, 1955-1976, 2020 | 39 | 2020 |
| Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment ZI Schwabkey, DH Wiesnoski, CC Chang, WB Tsai, D Pham, SS Ahmed, ... Science translational medicine 14 (671), eabo3445, 2022 | 33 | 2022 |
| Antibiotics application strategies to control biofilm formation in pathogenic bacteria F Khan, DTN Pham, SF Oloketuyi, YM Kim Current pharmaceutical biotechnology 21 (4), 270-286, 2020 | 31 | 2020 |
| Identification of drought-induced genes in giant leucaena (Leucaena leucocephala subsp. glabrata) MDH Honda, KL Ishihara, DT Pham, D Borthakur Trees 32, 571-585, 2018 | 25 | 2018 |
| Purification Process of Mangiferin from Mangifera indica L. Leaves and Evaluation of Its Bioactivities NTT Loan, DT Long, PND Yen, TTM Hanh, TN Pham, DTN Pham Processes 9 (5), 852, 2021 | 24 | 2021 |
| Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial TP Nguyen, Q Do, LT Phan, DV Dinh, H Khong, LV Hoang, TV Nguyen, ... The lancet regional health–Western Pacific 24, 2022 | 23 | 2022 |